In 560 cases of motor neuron disease, studied retrospectively from their case-
Methods

Patients and controls
The medical records of patients diagnosed with motor neuron disease at The London Hospital, London between 1965-82, at the Radcliffe Infirmary, Oxford between 1976-84, and at the National Hospital for Nervous Diseases, London between 1976-84 were reviewed. Cases were ascertained from the diagnostic index at each of these hospitals using the ICD codes 356-3 (1964-69), 348-9 (1970-78) and 335-2 (1977-84) . In these three centres the diagnosis was established in each case only after full clinical evaluation and investigation. The latter included haematological and liver function tests, and radiological studies and, in most cases cerebrospinal fluid (CSF) examination and electrophysiological studies.
In some, muscle biopsy and necropsy studies were available. The specificity of these diagnostic procedures in establishing the diagnosis of motor neuron disease from multiple sclerosis, cervical spondylosis with myelopathy and stroke, diseases with which motor neuron disease may easily be confused, has been studied previously using a discriminant analysis procedure in 362 of 378 cases.' This showed that 96% of these cases were correctly classified so that, for these hospitals, there was good agreement in the diagnostic criteria in use. The medical and occupational backgrounds of these patients were compared with those of 220 control patients, taken from the case records of the same three hospitals for the years 1981-84. These control patients suffered from Parkinson's disease, cervical spondylosis, or multiple sclerosis, and had been used as controls in our previous study of the differential diagnosis of motor neuron disease from other neurological conditions.' Sex and age of onset Of the 560 patients with motor neuron disease 342 (61%) were male, a sex ratio of 1-57:1. There was a marked male excess in patients presenting below the age of 60 years, but the sex distribution in patients presenting after this age was nearly equal (fig 1) . This change in sex ratio with increasing age was accounted for by the preponderance of women presenting with bulbar symptoms in the older age ranges (fig 2) . The mean age of onset for men was 54-6 years (SD 12-5 years) and for women 58 years (SD 11 4 years). In the whole group of 560 patients the mean age of onset was 56 years (range 13-87 years), although 71% reported the onset of symptoms between age 46 and 66 years ( fig 1) .
Age at death and duration of illness The age at death was recorded for only 125 of the 560 cases. In these patients the mean age at death was 57-4 years (SD 12-9 years), and the mean duration of illness was 2-6 years (SD 2-4 years). The age at death ranged from 22-88 years.
Symptoms and signs at presentation The majority of patients (63%) reported muscle weakness as the first symptom, 23% reported difficulty in speaking, 16% difficulty in walking and 11% muscle wasting. The disease started in the upper limbs in 44%, in the lower limbs in 37%, and in the bulbar muscles in 19%. The latter presentation was especially a feature of older women with motor neuron disease ( fig 2) . On examination, muscle weakness was noted in the upper limbs in 74% of the patients, and in the lower limbs Previous medical history There was a history of a surgical operation, ranging from tonsillectomy to hysterectomy, in 39% of patients with motor neuron disease. A crude comparison of the patients with motor neuron disease and the controls showed a similar rate for surgical procedures, although the mean age of the control subjects was less than that of the patients with motor neuron disease. Analysis of the prevalence of surgical operations in different age groups showed no significant trends or differences from the control patients. Only 0 9% of patients with motor neuron disease, and 0-5% of controls reported a history of poliomyelitis. There were no differences in the incidence of other medical conditions between the patients with motor neuron disease and the controls apart from Parkinson's disease, cervical spondylosis and multiple sclerosis, the diagnostic criteria by which these control patients were selected. Smoking is positively associated with a number of common and serious diseases, but in Parkinson's disease there is a negative association with smoking.2324 In our patients the prevalence of smoking was similar among patients with motor neuron disease and controls, but less than in the general population as reported in the General Household Survey,25 which showed that between 1972-80 smokers made up 50-64% of men and 37-41% of women in the general population. In our patients smoking showed an association with sex and age, but no independent association with motor neuron disease (p = 0-26).
Alcohol use, on the other hand, showed an overall negative association with motor neuron disease (p = 0 0055) compared with the controls. Our data, like those of Martyn et al,20 do not confirm the suggestion made by Hawkes et al 26 that motor neuron disease might be positively associated with occupational exposure to leather goods. No new epidemiological associations that might be important in pathogenesis have been revealed by this retrospective study, although several previously suggested associations have not been confirmed.
